Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Cash from Investing Activities (2021 - 2024)

Verrica Pharmaceuticals has reported Cash from Investing Activities over the past 4 years, most recently at $8000.0 for Q4 2024.

  • Quarterly results put Cash from Investing Activities at $8000.0 for Q4 2024, up 103.52% from a year ago — trailing twelve months through Dec 2025 was -$8000.0 (up 57.89% YoY), and the annual figure for FY2024 was -$19000.0, up 94.75%.
  • Cash from Investing Activities for Q4 2024 was $8000.0 at Verrica Pharmaceuticals, up from -$16000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for VRCA hit a ceiling of $43.0 million in Q1 2022 and a floor of -$22.1 million in Q2 2021.
  • Median Cash from Investing Activities over the past 4 years was $8000.0 (2024), compared with a mean of $3.5 million.
  • Biggest five-year swings in Cash from Investing Activities: soared 296.98% in 2022 and later crashed 103.36% in 2023.
  • Verrica Pharmaceuticals' Cash from Investing Activities stood at $4.0 million in 2021, then skyrocketed by 68.39% to $6.8 million in 2022, then crashed by 103.36% to -$227000.0 in 2023, then surged by 103.52% to $8000.0 in 2024.
  • The last three reported values for Cash from Investing Activities were $8000.0 (Q4 2024), -$16000.0 (Q3 2024), and -$11000.0 (Q2 2024) per Business Quant data.